Odds of FIT-based screening lower with suppression subdomains of ‘deny immediacy to be tested’ and ‘self-exemption’<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
TUESDAY, Feb. 7, 2023 (HealthDay News) — Defensive information processing (DIP) is a barrier to colorectal cancer screening uptake, according to a study published online Feb. 6 in Cancer<\/em>.<\/p>\n Nicholas Clarke, Ph.D., from Dublin City University in Ireland, and colleagues examined the correlation of DIP with fecal immunochemical test (FIT)-based colorectal cancer screening uptake using data from a cross-sectional survey within a population-based FIT screening program. The seven subdomains of the McQueen DIP measure were included in the survey, and their correlation with screening uptake status was assessed.<\/p>\n The researchers found that in a model adjusted for sociodemographic factors, there was a significant correlation for higher scores on all DIP domains, equating to greater defensiveness, with lower uptake of screening. The suppression subdomains of “deny immediacy to be tested” and “self-exemption” independently predicted nonuse of FIT-based screening in the model with additional adjustments for behavioral factors (odds ratios, 0.53 and 0.80, respectively).<\/p>\n “Suppressors who deny the immediacy to be screened may be amenable to behavioral interventions that nudge them to be screened. Suppressors who self-exempt themselves may require stronger educational and defensiveness-reducing interventions to encourage future screening participation,” the authors write.<\/p>\n Several authors disclosed financial ties to the biopharmaceutical and medical device industries.<\/p>\n